At least $16,949 in Medicaid payments in Red Oak went toward services billed under HCPCS codes designated for COVID-19 in 2024, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid is a public health insurance program operated by individual states with joint federal and state funding. It provides coverage for low-income people and families, seniors, children, and those with disabilities, making it a significant component of the U.S. health care system.
Because Medicaid funding is drawn from taxpayer dollars, shifts in billing levels offer insight into how public health funding is distributed locally.
For this story, COVID-19–related services were determined using HCPCS codes described or classified as “COVID-19” or “coronavirus” in their billing references. The figures cover only those services directly marked as COVID-related in billing systems, which means broader or differently classified pandemic care is not included in the count.
Houston posted the highest total in Texas for Medicaid payments linked to COVID-19 services in 2024, with virus-related claims reaching $5,684,946.
The average Medicaid payment per COVID-19 services provider in Red Oak was $8,474, below the Texas average of $40,722.
COVID-19–specific claims contributed to notable growth in local Medicaid spending during the core pandemic years in Red Oak.
In the two years before the pandemic, Red Oak averaged $571,776 in annual Medicaid payments.
According to the Centers for Medicare & Medicaid Services, federal and state Medicaid expenditures totaled about $871.7 billion in fiscal year 2023, accounting for roughly 18% of all national health expenses, significantly higher than the $613.5 billion recorded in 2019, before COVID-19 emerged.
This change represents an approximate 40% increase, fueled by expanded enrollment and greater service use through and after the pandemic period.
Legislation passed under the Trump administration recently brought major proposals to limit federal Medicaid funding and restructure the program. The “One Big Beautiful Bill Act,” enacted in 2025, is anticipated to decrease federal Medicaid spending by over $1 trillion over 10 years and brings policies like work requirements and higher cost-sharing, changes that may reduce insurance or funding for some beneficiaries. These adjustments are expected to move more responsibility to the states and slow the growth of federal support for Medicaid, despite the program’s size.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $16,949 | -42.9% | $820,347 |
| 2023 | $29,694 | 56.3% | $1,481,119 |
| 2022 | $18,999 | 10.4% | $1,538,111 |
| 2021 | $17,214 | N/A | $973,578 |
| 2020 | $0 | N/A | $319,576 |
| 2019 | $0 | N/A | $526,262 |
| 2018 | $0 | N/A | $617,290 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $16,949 | 478 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
The data in this report comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source data is available here.
